RYTM logo
Rhythm Pharmaceuticals, Inc.(RYTM)
Last print unknown agoAbout this dataData status
$88.23▲2.06 (2.39%)Stale · unknown old

RYTM R&D Expenses

$173.21MTTM · USD

Period ending:

RYTM FY R&D ExpensesUSD
RYTM FY R&D Expenses2012-12-31: $15.68M2013-12-31: $18.02M2014-12-31: $5.28M2015-12-31: $7.15M2016-12-31: $19.59M2017-12-31: $22.89M2018-12-31: $50.34M2019-12-31: $109.45M2020-12-31: $90.45M2021-12-31: $104.13M2022-12-31: $108.63M2023-12-31: $134.95M2024-12-31: $237.96M2025-12-31: $167.34M$237.96M$0.00
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RYTM r&d expenses history

Research and development spending. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Rhythm Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
167,340,000
237,957,000
134,951,000
108,630,000
104,128,000
90,450,000
109,450,000
50,337,000
22,894,000
19,594,000
7,148,000
5,280,000
18,015,000
15,678,000

Compare r&d expenses

All RYTM financial metrics · RYTM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.